MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-09-2026
Becton, Dickinson and Company Depreciation & Amortization 2011-2026 | BDX
Annual Depreciation & Amortization Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.46 B | 2.29 B | 2.29 B | 2.23 B | 2.23 B | 2.12 B | 2.25 B | 1.98 B | 1.09 B | 1.11 B | 891 M | 562 M | 546 M | 511 M | 494 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.46 B | 494 M | 1.54 B |
Quarterly Depreciation & Amortization Becton, Dickinson and Company
| 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 614 M | 397 M | 396 M | 607 M | 362 M | 366 M | 561 M | 367 M | 366 M | 567 M | - | 357 M | 352 M | 546 M | - | 1.11 B | 350 M | 555 M | 1.6 B | 1.07 B | 555 M | 530 M | 1.7 B | 1.13 B | 530 M | 563 M | 1.41 B | 844 M | 563 M | 291 M | 802 M | 523 M | 291 M | 262 M | 841 M | 569 M | 262 M | 289 M | 576 M | 277 M | 289 M | 139 M | 413 M | 272 M | 139 M | 142 M | 404 M | 265 M | 142 M | 129 M | 384 M | 261 M | 129 M | 133 M | -365 M | -245 M | 136 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.7 B | -365 M | 475 M |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M |  USA |
 |
iRhythm Technologies
IRTC
|
20.7 M | $ 126.93 | 3.74 % | $ 4.06 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
1.57 M | $ 10.93 | -0.55 % | $ 26.5 M | USA |
 |
The Cooper Companies
COO
|
377 M | $ 64.3 | -0.19 % | $ 12.8 B | USA |
 |
Repro Med Systems
KRMD
|
810 K | $ 4.03 | 1.77 % | $ 186 M | USA |
 |
Microbot Medical
MBOT
|
47 K | $ 2.17 | -1.36 % | $ 99.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
78.2 K | $ 0.32 | 1.15 % | $ 26.3 M | USA |
 |
Haemonetics Corporation
HAE
|
116 M | $ 60.81 | 1.38 % | $ 3.06 B | USA |
 |
electroCore
ECOR
|
501 K | $ 6.07 | -1.7 % | $ 51.5 K | USA |
 |
ICU Medical
ICUI
|
201 M | $ 122.32 | -2.0 % | $ 3.01 B | USA |
 |
Envista Holdings Corporation
NVST
|
116 M | $ 26.79 | - | $ 4.5 B | USA |
 |
Isoray
ISR
|
3.25 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
600 M | $ 471.29 | -2.27 % | $ 168 B | USA |
 |
Glaukos Corporation
GKOS
|
33.7 M | $ 121.88 | 0.18 % | $ 5.9 B | USA |
 |
STERIS plc
STE
|
476 M | $ 221.92 | 0.08 % | $ 21.9 B | USA |
 |
Teleflex Incorporated
TFX
|
178 M | $ 136.38 | -0.13 % | $ 6.09 B | USA |
 |
Masimo Corporation
MASI
|
103 M | $ 178.6 | -0.02 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
13.4 M | $ 10.6 | 2.71 % | $ 219 M | USA |
 |
Merit Medical Systems
MMSI
|
123 M | $ 67.27 | -1.91 % | $ 3.98 B | USA |
 |
Utah Medical Products
UTMD
|
826 K | $ 67.07 | -0.15 % | $ 217 M | USA |
 |
West Pharmaceutical Services
WST
|
171 M | $ 301.01 | -1.6 % | $ 21.8 B | USA |
 |
Pulse Biosciences
PLSE
|
406 K | $ 22.39 | -2.74 % | $ 1.51 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
352 M | $ 11.9 | -0.13 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
7.77 M | $ 0.63 | -1.72 % | $ 18.9 M | USA |
 |
Pro-Dex
PDEX
|
1.24 M | $ 51.94 | -0.32 % | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
10.4 M | $ 115.31 | 1.64 % | $ 2.61 B | USA |
 |
Predictive Oncology
POAI
|
129 K | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
8.32 M | $ 26.2 | 2.06 % | $ 1.3 B | USA |
 |
BioLife Solutions
BLFS
|
5.16 M | $ 21.31 | -0.33 % | $ 982 M | USA |
 |
Stereotaxis
STXS
|
626 K | $ 1.94 | 0.26 % | $ 176 M | USA |
 |
Baxter International
BAX
|
981 M | $ 18.46 | 1.68 % | $ 9.47 B | USA |
 |
ResMed
RMD
|
160 M | $ 222.96 | 1.47 % | $ 32.6 B | USA |
 |
AtriCure
ATRC
|
12.1 M | $ 29.06 | -0.75 % | $ 1.39 B | USA |
 |
Harvard Bioscience
HBIO
|
1.74 M | $ 6.56 | -4.37 % | $ 291 M | USA |
 |
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
25.8 M | $ 11.01 | -0.81 % | $ 450 M | USA |
 |
Nephros
NEPH
|
214 K | $ 2.99 | 4.3 % | $ 31.1 M | USA |
 |
OraSure Technologies
OSUR
|
10.2 M | $ 2.97 | -1.17 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
68.6 M | $ 118.39 | 0.67 % | $ 6.6 M | USA |